US Patent 10358427 Modulators of indoleamine 2,3-dioxygenase
Patent 10358427 was granted and assigned to GlaxoSmithKline on July, 2019 by the United States Patent and Trademark Office.
Is a
Current Assignee
Date Filed
September 22, 2016
0
Date of Patent
July 23, 2019
0
Patent Applicant
Patent Application Number
15759950
0
Patent Citations Received
Patent Inventor Names
Vicente Samano
0
Hamilton D. Dickson
0
Martha Alicia De La Rosa
0
Pek Yoke Chong
0
Wieslaw Mieczyslaw Kazmierski
0
Vincent Wing-Fai Tai
0
Patent Jurisdiction
Patent Number
Patent Primary Examiner
Find more entities like US Patent 10358427 Modulators of indoleamine 2,3-dioxygenase
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
